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During development, skeletal muscles adapt to stage-specific functional and metabolic challenges by
switching the expression of specific subset of genes. Themechanism that governs these changes is still enig-
matic. In a recent issue of Cell, Messina and coworkers shed light on this issue through the identification of
a transcription factor—NFix—that coordinates the switch in gene expression at the transition from embryonic
to fetal myoblasts.Every transition in life requires that the
preexisting status be erased prior to
stepping into a new stage. For instance,
it is notoriously difficult to move into
a new relationship if the previous one
has not been resolved. An analogous situ-
ation applies to embryo development,
during the transition from one stage to
another. Skeletal myogenesis occurs in
successive steps, each of them involving
distinct progenitor cell types and specific
patterns of gene expression (Bryson-
Richardson and Currie, 2008). The first
muscle fibers in the embryo appear by
day e11 from the fusion of embryonic
myoblasts. By day 16 a second wave of
myogenesis is driven by fetal myoblasts,
which give rise to most of the adult mus-
culature. In postnatal life, muscle growth
and regeneration occurs at the expense
of a heterogeneous population of adult
muscle progenitors—the satellite cells.
Embryonic, fetal, and adult muscle pro-
genitors show different patterns of gene
expression that comply with stage-
specific activities (Gunning and Harde-
man, 1991). Switching on or off specific
subsets of genes at each transition is
therefore a critical challenge faced by
developmental myogenesis. Despite the
knowledge of the molecular networksthat specify the myogenic lineage and
activate skeletal myogenesis by the coop-
erative activity of different transcription
factors (Guasconi and Puri, 2009), the
identities of the cellular factors that coor-
dinate gene repression and activation at
each transition remains elusive. In a recent
Cell paper, Messina et al. (2010) demon-
strate that a single transcription factor—
nuclear factor I-x (Nfix)—is necessary
and sufficient to mediate the transcrip-
tional switch between embryonic and fetal
myogenesis.
Nfix belongs to a class of transcription
factors consisting of four closely related
genes—Nfia, Nffb, Nfic, and Nfix—that
are involved in the control of gene expres-
sion in a variety of cell types and tissues
(Gronostajski, 2000). Nfi-binding sites
have been implicated both in gene activa-
tion and repression, but the mechanism
by which they modulate transcription is
still obscure. Nfi proteins bind to DNA
either as homodimers or heterodimers
with other family members through an
N-terminal region; the C-terminal region
is highly variable, as the result of exten-
sive alternative splicing, and contains
domains responsible for transcriptional
activation or repression (Gronostajski,
2000). Mouse models in which theexpression of the different family mem-
bers has been ablated have revealed the
role of Nfia and Nfib in brain development
(with Nfib being also essential for lung
maturation) and of Nfic in correct tooth
formation. Nfix-deficient mice die soon
after birth with defects in brain, intestine,
and skeleton (Pekarik and Belmonte,
2008). Thus, the discovery by Messina
et al. (2010) that Nfix has a crucial role
in skeletal myogenesis is unanticipated.
A genome-wide screen in fetal versus
embryonic myoblasts, previously per-
formed by the same group, showed an
abundant and preferential expression of
Nfix in fetal myoblasts (Biressi et al.,
2007). Messina et al. (2010) now use
a combination of assays in established
and primary (embryonic or fetal) mouse
muscle cells to demonstrate the role of
Nfix in the activation of gene expression
typical of fetal myoblasts. In vivo experi-
ments show that conditional ablation of
Nfix in MyoD-expressing cells prevents
the initiation of fetal-specific transcription.
Consistently, premature expression of
Nfix in embryonic myoblasts leads to an
anticipated activation of fetal genes and
suppression of embryonic genes. This
evidence led the authors to conclude
that Nfix coordinates gene expression
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promoting fetal gene expression
and repressing embryonic genes. Inter-
estingly, the mechanism of Nfix-mediated
regulation of gene expression appears
extremely multifaceted and gene-specific.
Nfix-mediated activation of the fetal
muscle-specific enzyme MCK occurs
through an interaction with MEF2A and
PKC-theta, leading to PKC-mediated
phosphorylation of MEF2A that enables
the latter to activate transcription. Curi-
ously, Nfix and MEF2A occupy the
enhancer/promoter regions of MCK in the
absence of PCK-theta, suggesting two
spatially separated activities of Nfix—one
to allow PKC-mediated phosphoryla-
tion of MEF2A, presumably away from
the chromatin, and another to promote
MEF2A-directed transcription of MCK,
through chromatin interactions. By con-
trast, activation of beta enolase in fetal
muscle does not require the formation of
a PKC-containing complex. Repression of
embryonic genes, such as slow embryonic
myosin heavy chain (MyHC), is achieved
by an indirect mechanism consisting of
Nfix-mediated repression of NFATc4,
which is the physiological activator of
embryonic MyHC transcription. Thus,
further studies will be needed to elucidate
the molecular mechanism involved in
Nfix-mediated regulation of target genes.
Another interesting issue raised by this
work relates to the putative role of Nfix
during adult muscle regeneration. In fetal
myoblasts, Nfix is activated by the tran-
scription factor Pax7, which is typically
expressed in satellite cells. Two pieces
of evidence from previous work (dis-
cussed in Messina et al., 2010) support
the idea of a more general role for Nfix
during myogenesis, beyond the embry-
onic-to-fetal transition. Nfi-binding sites
are present on the myogenin promoter,
and Nfi can form a complex with this
transcription factor, increasing its affinity
for some target genes. Future work will
determine if Nfix mediates Pax7 down-
stream functions in satellite cells.Overall, the work of Messina et al.
(2010) points to a general role for Nfi
proteins in the control of cell fate and
lineage switching during development.
This concept is supported by a recent
study showing that Nfia expression dic-
tates the differentiation of hematopoietic
progenitors along the erythroid lineage
while suppressing granulocyte differenti-
ation (Starnes et al., 2009). In analogy
with the myogenic program, this effect is
mediated, at least in part, by a dual and
opposite effect in the activation and
repression of erythroid and granulocytic
genes.
The idea that a single factor can both
activate and repress different subsets of
genes within the same cell is highly
provocative and opens a number of inter-
esting avenues for future work. The ability
of Nfix to do so implies that it is simulta-
neously recruited to the chromatin of
different target genes as part of distinct
complexes endowed with either acti-
vating or repressive activities. It is likely
that intracellular signaling cascades, trig-
gered by extrinsic signals in the embryo,
dictate the chromatin distribution of Nfix
together with other muscle transcription
factors during successive waves of myo-
genesis. Since Nfix binds to palindromic
consensus sequences, it is likely that
sequences adjacent to Nfix binding sites
determine the recruitment of coactivators
or corepressors that ultimately endow
Nfix with the ability to either promote or
repress gene transcription. For instance,
when Nfix is recruited to enhancer/pro-
moters regions of muscle genes in the
proximity of MEF2-binding sites, it might
synergize with MEF2-associated acti-
vating complexes. Given the presence of
MEF2-binding sites and Ebox sequences
(bound by muscle bHLH proteins) on
enhancer/promoter elements of muscle
genes, an open question relates to the
possibility that Nfix can promote the func-
tional cooperation between MEF2 and
muscle bHLH proteins (Molkentin and
Olson, 1996) to activate fetal muscleDevelopmental Cell 1genes. Since MEF2 factors can associate
either with transcriptional activators or
repressors in response to specific sig-
naling cascades (Potthoff and Olson,
2007), it is also possible that MEF2-asso-
ciated Nfix obeys the same signal-depen-
dent regulation. Alternatively, it is possible
that the presence of other regulatory
sequences result in a repressive function
for Nfix. Future work, including con-
ditional knock-out strategies, should
extend our knowledge of the function
of Nfix during skeletal myogenesis.
Moreover, the analysis of mice whose
adult muscles have developed in the
absence of Nfix will reveal whether—like
relationships that falter when former
attachments still linger—failure to coordi-
nate gene expression during embryonic-
to-fetal gene switch has catastrophic
consequences.REFERENCES
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